Founded in 1991, the Industries Médico-Chirurgicales (I.M.C) specializes in the manufacturing and marketing of single-use medical devices, as well as bulk solutions and other injectable medicines. Since its inception, IMC has aimed to position itself as a leader in the medical equipment sector in Algeria, focusing on the quality and reliability of its products.

IMC is also involved in the installation and maintenance of various medical equipment, such as dialysis machines, water treatment, apheresis, and in vitro diagnostics. The company has established itself in the hospital sector thanks to its technical expertise and ability to meet the needs of healthcare professionals with cutting-edge products.

In addition, IMC treats hemodialysis patients through its 17 Renadial clinics spread across the country. These clinics are equipped with the latest medical technologies to provide high-quality care to over 1,000 dialysis patients. Thanks to the expertise of its medical team and modern facilities, Renadial has become a key player in chronic kidney disease (CKD) care.

With a workforce of 1,665 employees at IMC and 500 at Renadial, the company has a hospital focus and boasts 30 years of experience in managing chronic diseases, particularly chronic kidney disease (CKD) through hemodialysis. This expertise is also reflected in the ongoing training of medical teams and the development of new treatments and technologies aimed at improving patients' lives.

IMC demonstrates a strong commitment to investing in local manufacturing, with a recognized pharmaceutical industrial base comprising 6 production units located in industrial zones in Algiers. The company continues to innovate to meet international standards and ensure high-quality products, locally manufactured to meet national and international demand.

It complies with international standards in the field, such as Good Manufacturing Practices (GMP) and ISO 9001 since 2001, as well as CE marking since 2006, and has focused on exportation since its inception. The export strategy allows IMC to diversify and expand its market by offering its products to other countries while maintaining an impeccable level of quality.

History of achievements:

• 1989: Creation of Sarl IMC (private capital)
• 1994: Marketing of dialysis equipment
• 1998: Syringe manufacturing
• 2002: First bulk solution unit (partnership with Aguettant laboratories)
• 2002: Creation of Renadial subsidiary (hemodialysis clinic)
• 2006: First bulk solution unit (BFS system)
• 2006: Expansion of the company's hospital offering
• 2008: Launch of the 3rd small volume unit
• 2011: Study for expansion of BFS capacity
• 2016: Entry into production of the 4th bulk solution unit
• 2020: Entry into production of a new hemodialysis concentrate unit

TIMC operates state-of-the-art laboratories for quality control and is validated by the National Pharmaceutical Product Control Laboratory. This certification process reinforces IMC's credibility as a leader in the medical device sector. The company is fully committed to adhering to the strictest quality standards in the manufacturing and distribution of its products.

With ISO 9001 certifications since 2001, IMC demonstrates its commitment to rigorous quality standards. This certification guarantees healthcare professionals and patients that IMC products meet strict criteria for performance, safety, and durability. Every step of production, from design to manufacturing, is conducted with particular attention to continuous improvement and customer satisfaction.

IMC also places great emphasis on managing the traceability of products to ensure compliance with international requirements. The company has implemented an effective internal control system that prevents any anomalies and optimizes the production chain.

Beyond certifications, IMC is invested in innovation and research and development to offer ever more effective products. For example, the company has developed a range of medical devices for dialysis and hemodialysis care, providing patients with a better quality of life through state-of-the-art equipment.

Moreover, IMC has recently expanded its portfolio of certifications by obtaining CE certification, enabling it to market its products internationally. This recognition is a testament to IMC's ability to meet European standards for safety and performance.

IMC continues to advance its mission of providing superior-quality products while strengthening its position in both the Algerian and international markets. The company is constantly evolving to meet public health challenges and contribute to the improvement of healthcare in the country.

From hemodialysis devices to bulk solutions, explore our wide range of high-quality medical products. IMC offers a variety of products suited to the needs of healthcare professionals and patients. The company stands out for its ability to provide innovative and high-performance medical products that meet the strict requirements of hospitals and healthcare clinics.

Our range of medical products includes single-use medical devices such as syringes, catheters, filters, and dialysis devices. These products are manufactured according to the highest quality standards to ensure their safety and effectiveness. IMC products are used in hospitals and clinics throughout Algeria, thereby contributing to the improvement of healthcare quality.

In addition to medical devices, IMC also offers bulk solutions for hemodialysis, a specialty that has allowed IMC to position itself as a key player in treating renal failure patients. The company is committed to producing high-quality solutions, in compliance with international standards, to ensure optimal effectiveness during treatments.

IMC has also developed a range of in vitro diagnostic products, another aspect of its commitment to providing complete medical solutions for patient care. These products enable healthcare professionals to diagnose various medical conditions quickly and accurately, thereby contributing to more effective and tailored treatments.

Finally, IMC places great emphasis on innovation in research and development. The company invests in cutting-edge technologies to create even more effective medical products tailored to current healthcare needs. Thanks to its many years of experience, IMC continues to stand out in the healthcare sector in Algeria and other international markets.